Provided by Tiger Trade Technology Pte. Ltd.

Liquidia Technologies Inc

35.50
-0.9100-2.50%
Post-market: 35.500.00000.00%16:51 EDT
Volume:1.08M
Turnover:38.98M
Market Cap:3.13B
PE:-44.33
High:37.45
Open:36.41
Low:35.08
Close:36.41
52wk High:46.67
52wk Low:11.26
Shares:88.11M
Float Shares:61.27M
Volume Ratio:1.05
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8009
EPS(LYR):-0.8009
ROE:-111.05%
ROA:-11.50%
PB:69.90
PE(LYR):-44.33

Loading ...

CORRECTED-Pulmonary drug developer Liquidia posts operating profit in first full quarter of YUTREPIA sales

Reuters
·
Nov 03, 2025

Earnings Flash (LQDA) Liquidia Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
Nov 03, 2025

Stock Track | Liquidia Technologies Soars 5.62% Pre-Market on Strong Q3 Results, Beating Revenue Estimates

Stock Track
·
Nov 03, 2025

BRIEF-Liquidia LIQUIDIA Q3 EPS USD -0.04 VS. IBES ESTIMATE USD -0.4

Reuters
·
Nov 03, 2025

Liquidia Corporation reports $51.7 million in YUTREPIA net product sales for Q3 2025

Reuters
·
Nov 03, 2025

Liquidia Q3 Operating Income USD 1.767 Million

THOMSON REUTERS
·
Nov 03, 2025

CORRECTED-Liquidia Q3 REVENUE USD 54.342 million vs. IBES estimate USD 18.8 million (CORRECTS AMOUNT)

THOMSON REUTERS
·
Nov 03, 2025

BRIEF-Liquidia Corp - Unit Enters Exclusive Licensing Agreement With Vectura - SEC Filing

Reuters
·
Oct 30, 2025

Liquidia Signs Exclusive Licensing Agreement With Vectura for Treprostinil Products in US

Reuters
·
Oct 30, 2025

Liquidia Technologies (LQDA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Oct 29, 2025

Evaluating Liquidia (LQDA): Is the Current Valuation Justified by Its Recent Rally?

Simply Wall St.
·
Oct 29, 2025

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire
·
Oct 27, 2025

Liquidia Corporation CEO Roger Jeffs Reports Disposal of Common Shares

Reuters
·
Oct 16, 2025

Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says

MT Newswires Live
·
Oct 09, 2025

BofA Adjusts Price Target on Liquidia to $37 From $35

MT Newswires Live
·
Oct 09, 2025

Liquidia price target raised to $37 from $35 at BofA

TIPRANKS
·
Oct 09, 2025

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

GlobeNewswire
·
Oct 07, 2025

Liquidia Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 06, 2025

BTIG biotech analyst holds an analyst/industry conference call

TIPRANKS
·
Oct 04, 2025

Liquidia Corporation to Present New ASCENT Trial Data on Inhaled Treprostinil for PH-ILD at CHEST 2025 Annual Meeting

Reuters
·
Sep 29, 2025